Dimeric prodrug-based nanomedicines for cancer therapy.

Autor: Li, Shumeng1 (AUTHOR), Shan, Xinzhu1 (AUTHOR), Wang, Yuequan1 (AUTHOR), Chen, Qin2 (AUTHOR), Sun, Jin1 (AUTHOR), He, Zhonggui1 (AUTHOR), Sun, Bingjun1 (AUTHOR) sunbingjun_spy@sina.com, Luo, Cong1 (AUTHOR) luocong@syphu.edu.cn
Zdroj: Journal of Controlled Release. Oct2020, Vol. 326, p510-522. 13p.
Databáze: Academic Search Ultimate